
### [NCIT:C6602](http://purl.obolibrary.org/obo/NCIT_C6602)
**Label:** Benign Osteogenic Neoplasm

**Subclasses:** [NCIT:C129569](http://purl.obolibrary.org/obo/NCIT_C129569) (Skull Osteoma), [NCIT:C121923](http://purl.obolibrary.org/obo/NCIT_C121923) (Ivory Exostosis), [NCIT:C3294](http://purl.obolibrary.org/obo/NCIT_C3294) (Osteoblastoma), [NCIT:C3297](http://purl.obolibrary.org/obo/NCIT_C3297) (Osteoid Osteoma), [NCIT:C3296](http://purl.obolibrary.org/obo/NCIT_C3296) (Osteoma), [NCIT:C121924](http://purl.obolibrary.org/obo/NCIT_C121924) (Enostosis), 

**Class expressions from DL-Learner:**

- [NCIT:C53444](http://purl.obolibrary.org/obo/NCIT_C53444) (Osseous Differentiation) 56.25%
- [NCIT:C36105](http://purl.obolibrary.org/obo/NCIT_C36105) (Indolent Clinical Course) 56.25%
- [CL:0000062](http://purl.obolibrary.org/obo/CL_0000062) (osteoblast) 56.25%
- Thing 52.26%
- [NCIT:C12555](http://purl.obolibrary.org/obo/NCIT_C12555) (Connective and Soft Tissue Cell) 35.12%
- [NCIT:C41405](http://purl.obolibrary.org/obo/NCIT_C41405) (Neuron, Neuroepithelial Cell, and Supporting Cell of the Nervous System) 31.25%
- [NCIT:C36900](http://purl.obolibrary.org/obo/NCIT_C36900) (Neoplastic Osteoblast) 31.25%
- [NCIT:C12964](http://purl.obolibrary.org/obo/NCIT_C12964) (Connective and Soft Tissue) 28.61%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 27.84%
- [NCIT:C36190](http://purl.obolibrary.org/obo/NCIT_C36190) (Mesenchymal Differentiation) 25.15%
- [CL:0000000](http://purl.obolibrary.org/obo/CL_0000000) (cell) 25.03%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 24.68%
- [CL:0000055](http://purl.obolibrary.org/obo/CL_0000055) (non-terminally differentiated cell) 22.92%
- [CL:0011115](http://purl.obolibrary.org/obo/CL_0011115) (precursor cell) 16.68%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 15.85%


